1. Honecker F, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, et al. ESMO consensus conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol. 2018;29(8):1658–86.
2. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. International germ cell cancer collaborative group. J Clin Oncol. 1997;15(2):594–603.
3. Seidel C, Daugaard G, Tryakin A, Necchi A, Cohn-Cedermark G, Ståhl O, et al. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: a registry of the international global germ cell tumor collaborative group (G3). Urol Oncol. 2019;37(11):809–e25.
4. Necchi A, Pond GR, Nicolai N, Giannatempo P, Raggi D, Adra N, et al. A suggested prognostic reclassification of intermediate and poor-risk nonseminomatous germ cell tumors. Clin Genitourin Cancer. 2017;15(2):306–e3.
5. Heidenreich A, Bokemeyer C, Souchon R. Stadienspezifische Therapie testikulärer Keimzelltumoren. Urologe. 2009;48(4):377–85.